Last reviewed · How we verify

Diosmin / Hesperidin — Competitive Intelligence Brief

Diosmin / Hesperidin (Diosmin / Hesperidin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bioflavonoid / Venoactive agent. Area: Cardiovascular / Vascular disorders.

marketed Bioflavonoid / Venoactive agent Cardiovascular / Vascular disorders Small molecule Live · refreshed every 30 min

Target snapshot

Diosmin / Hesperidin (Diosmin / Hesperidin) — Pirogov Russian National Research Medical University. Diosmin and hesperidin are bioflavonoids that strengthen blood vessel walls and improve microcirculation by reducing capillary fragility and enhancing venous tone.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Diosmin / Hesperidin TARGET Diosmin / Hesperidin Pirogov Russian National Research Medical University marketed Bioflavonoid / Venoactive agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bioflavonoid / Venoactive agent class)

  1. Pirogov Russian National Research Medical University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Diosmin / Hesperidin — Competitive Intelligence Brief. https://druglandscape.com/ci/diosmin-hesperidin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: